Abstract
Mitochondria are key organelles involved, among others, in the ATP synthesis. Mitochondrial physiology is strictly dependent on its integrity. Since ATP synthesis is necessary to many of the physiological processes in cells, changes in mitochondrial physiology and/or integrity are of particular importance to cell activity. Mitochondrial dysfunction could lead to apoptotic cell death, which is often associated with the release of “mitochondrial factors”, under these situations. Therefore, drugs targeting this organelle are of interest in the pharmacological and/or toxicological research field. In this sense, organochalcogens (especially organoselenium and organotellurium compounds) are known to have a variety of pharmacological and/or toxicological properties. However, data concerning its effects on mitochondrial activity are still limited. Indeed, the basic molecular mechanism(s) involved in their mitochondrial effect is a critical point that deserves further attention. In this mini-review we sought to discuss the current scenario about the effect of some organoselenium and organotellurium compounds on mitochondrial function/activity, to better understand/ correlate the pharmacological/toxicological activity associated with these molecules.
Keywords: Organochalcogens, selenium, tellurium, mitochondria, apoptosis.
Current Organic Chemistry
Title:Mitochondrial Effects of Organoselenium and Organotellurium Compounds
Volume: 20 Issue: 2
Author(s): Robson L. Puntel, Daiana S. Avila, Daniel H. Roos and Simone Pinton
Affiliation:
Keywords: Organochalcogens, selenium, tellurium, mitochondria, apoptosis.
Abstract: Mitochondria are key organelles involved, among others, in the ATP synthesis. Mitochondrial physiology is strictly dependent on its integrity. Since ATP synthesis is necessary to many of the physiological processes in cells, changes in mitochondrial physiology and/or integrity are of particular importance to cell activity. Mitochondrial dysfunction could lead to apoptotic cell death, which is often associated with the release of “mitochondrial factors”, under these situations. Therefore, drugs targeting this organelle are of interest in the pharmacological and/or toxicological research field. In this sense, organochalcogens (especially organoselenium and organotellurium compounds) are known to have a variety of pharmacological and/or toxicological properties. However, data concerning its effects on mitochondrial activity are still limited. Indeed, the basic molecular mechanism(s) involved in their mitochondrial effect is a critical point that deserves further attention. In this mini-review we sought to discuss the current scenario about the effect of some organoselenium and organotellurium compounds on mitochondrial function/activity, to better understand/ correlate the pharmacological/toxicological activity associated with these molecules.
Export Options
About this article
Cite this article as:
L. Puntel Robson, S. Avila Daiana, H. Roos Daniel and Pinton Simone, Mitochondrial Effects of Organoselenium and Organotellurium Compounds, Current Organic Chemistry 2016; 20 (2) . https://dx.doi.org/10.2174/1385272819666150724234948
DOI https://dx.doi.org/10.2174/1385272819666150724234948 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
Current Medicinal Chemistry Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors
Current Medicinal Chemistry Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
Current Cancer Drug Targets The True Face of the Revolution in Oncology Drug Development: A Personal Reflection
Current Clinical Pharmacology Drug Eluting Stents and Beyond
Current Pharmaceutical Design A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents
Current Organic Synthesis Leveraging on Active Site Similarities; Identification of Potential Inhibitors of Zinc-Finger and UFSP domain Protein (ZUFSP)
Current Pharmaceutical Biotechnology In Vitro Inhibition Effect and Molecular Docking Study of Curcumin, Resveratrol, and Quercetin on Human Erythrocyte Glutathione Transferase
Current Enzyme Inhibition Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine
Current Pharmaceutical Design Synthesis and Characterization of Cu-SnO2 Nanoparticles Deposited on Glass Using Ultrasonic Spray Pyrolysis and their H2S Sensing Properties
Current Nanoscience Clinical Impact of Gastric Acid Suppressants Use on the Efficacy of Gefitinib in Patients with Advanced Adenocarcinoma of the Lung Harboring Common EGFR Mutations
Clinical Cancer Drugs CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets New Target Therapies for Brain Metastases from Breast Cancer
Current Cancer Drug Targets Immunomodulation Via Targeted Inhibition of Antigen Receptor Signal Transduction
Cardiovascular & Hematological Disorders-Drug Targets Antiproliferative Effects of Nerium oleander Leaves and Their Cardiac Glycosides Odoroside A and Oleandrin on MCF-7 Cancer Cells
Current Traditional Medicine Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?
Recent Patents on Anti-Cancer Drug Discovery Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology